Porcilis Pesti

RSS

Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against classical swine fever
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Porcilis Pesti has been withdrawn at the request of the marketing authorisation holder

български (BG) (389.2 KB - PDF)

Zobacz

español (ES) (186.61 KB - PDF)

Zobacz

čeština (CS) (318.5 KB - PDF)

Zobacz

dansk (DA) (190.05 KB - PDF)

Zobacz

Deutsch (DE) (357.3 KB - PDF)

Zobacz

eesti (ET) (186.1 KB - PDF)

Zobacz

ελληνικά (EL) (390.9 KB - PDF)

Zobacz

français (FR) (186.87 KB - PDF)

Zobacz

italiano (IT) (186.4 KB - PDF)

Zobacz

latviešu (LV) (489.86 KB - PDF)

Zobacz

lietuvių (LT) (299.13 KB - PDF)

Zobacz

magyar (HU) (476.92 KB - PDF)

Zobacz

Nederlands (NL) (186.4 KB - PDF)

Zobacz

polski (PL) (512.21 KB - PDF)

Zobacz

português (PT) (186.65 KB - PDF)

Zobacz

română (RO) (294.11 KB - PDF)

Zobacz

slovenčina (SK) (313.22 KB - PDF)

Zobacz

slovenščina (SL) (305.31 KB - PDF)

Zobacz

suomi (FI) (186.2 KB - PDF)

Zobacz

svenska (SV) (200.67 KB - PDF)

Zobacz

Product information

български (BG) (857.85 KB - PDF)

Zobacz

español (ES) (220.29 KB - PDF)

Zobacz

čeština (CS) (416.9 KB - PDF)

Zobacz

dansk (DA) (226.72 KB - PDF)

Zobacz

Deutsch (DE) (430.62 KB - PDF)

Zobacz

eesti (ET) (269.28 KB - PDF)

Zobacz

ελληνικά (EL) (854.2 KB - PDF)

Zobacz

français (FR) (249.26 KB - PDF)

Zobacz

italiano (IT) (226.44 KB - PDF)

Zobacz

latviešu (LV) (692.49 KB - PDF)

Zobacz

lietuvių (LT) (322.35 KB - PDF)

Zobacz

magyar (HU) (651.75 KB - PDF)

Zobacz

Malti (MT) (473.32 KB - PDF)

Zobacz

Nederlands (NL) (223.73 KB - PDF)

Zobacz

polski (PL) (531.76 KB - PDF)

Zobacz

português (PT) (222.35 KB - PDF)

Zobacz

română (RO) (323.19 KB - PDF)

Zobacz

slovenčina (SK) (437.6 KB - PDF)

Zobacz

slovenščina (SL) (427.77 KB - PDF)

Zobacz

suomi (FI) (224.06 KB - PDF)

Zobacz

svenska (SV) (286.33 KB - PDF)

Zobacz

Íslenska (IS) (223.38 KB - PDF)

Zobacz

norsk (NO) (282.92 KB - PDF)

Zobacz
Latest procedure affecting product information:R/0011
16/09/2011

български (BG) (257.17 KB - PDF)

Zobacz

español (ES) (190.85 KB - PDF)

Zobacz

čeština (CS) (218.43 KB - PDF)

Zobacz

dansk (DA) (191.13 KB - PDF)

Zobacz

Deutsch (DE) (342.19 KB - PDF)

Zobacz

eesti (ET) (189.44 KB - PDF)

Zobacz

ελληνικά (EL) (235.88 KB - PDF)

Zobacz

français (FR) (190.16 KB - PDF)

Zobacz

italiano (IT) (174.2 KB - PDF)

Zobacz

latviešu (LV) (388.87 KB - PDF)

Zobacz

lietuvių (LT) (220.48 KB - PDF)

Zobacz

magyar (HU) (366.11 KB - PDF)

Zobacz

Malti (MT) (251.16 KB - PDF)

Zobacz

Nederlands (NL) (189.72 KB - PDF)

Zobacz

polski (PL) (237.03 KB - PDF)

Zobacz

português (PT) (173.99 KB - PDF)

Zobacz

română (RO) (219.79 KB - PDF)

Zobacz

slovenčina (SK) (249.67 KB - PDF)

Zobacz

slovenščina (SL) (239.92 KB - PDF)

Zobacz

suomi (FI) (190.65 KB - PDF)

Zobacz

svenska (SV) (191.41 KB - PDF)

Zobacz

Íslenska (IS) (189.98 KB - PDF)

Zobacz

norsk (NO) (174.66 KB - PDF)

Zobacz

Product details

Name of medicine
Porcilis Pesti
Active substance
Classical Swine Fever Virus (CSFV) -E2 subunit antigen
International non-proprietary name (INN) or common name
adjuvanted vaccine against classical swine fever
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AD04

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000046
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
09/06/2000
Revision
12

Assessment history

This page was last updated on

Share this page